tezosentan has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceylan, BG; Gulmen, S; Kiris, I; Mermi, B; Meteoglu, I; Narin, C; Sutcu, R | 1 |
| Breu, V; Clozel, JP; Clozel, M; Coassolo, P; Hess, P; Löffler, BM; Ramuz, H; Roux, S | 1 |
2 other study(ies) available for tezosentan and Acute Kidney Failure
| Article | Year |
|---|---|
Tezosentan reduces the renal injury induced by abdominal aortic ischemia-reperfusion in rats.
Topics: Acute Kidney Injury; Animals; Aorta, Abdominal; Aortic Diseases; Catalase; Endothelin Receptor Antagonists; Female; Kidney Glomerulus; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Oxidative Stress; Peroxidase; Postoperative Complications; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Tetrazoles; Vasodilator Agents | 2009 |
Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use.
Topics: Acute Kidney Injury; Animals; Aorta, Thoracic; Cell Adhesion; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Humans; In Vitro Techniques; Macaca fascicularis; Macaca mulatta; Male; Microsomes; Pyridines; Rabbits; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Spodoptera; Tetrazoles; Trachea | 1999 |